1Dept. of Internal Medicine, Kyushu University, Faculty of Medicine.
The v-src oncogene confers resistance to Cisplatin (CDDP) chemotherapy by altering DNA repair pathways. Targeting intracellular signaling pathways may reverse this drug resistance in cancer treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: